RecruitingNCT06335342
Radiotherapy Treatments for Neoplasms in the Head and Neck Region
Sponsor
European Institute of Oncology
Enrollment
4,050 participants
Start Date
Feb 22, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The aim of this study is the evaluation of clinical and dosimetric aspects, tolerance, and effectiveness of radiotherapy treatments in the head and neck region. Eligible patients undergoing radiotherapy for primary or secondary neoplasms localized in the head and neck anatomical region.
Eligibility
Min Age: 18 Years
Inclusion Criteria8
- Patients treated with radiotherapy for curative, palliative, neo-adjuvant, and adjuvant purposes in the head and neck region include those with:
- Primary bone tumors,
- Primary soft tissue tumors,
- Primary tumors of the cardio-circulatory system,
- Primary tumors of the lymphatic system,
- Primary tumors of the nervous system and skin,
- Secondary metastases from various origins localized in that district.
- Signed informed consent
Exclusion Criteria1
- • Radiotherapy in districts other than the head and neck region
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06335342
Related Trials
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
NCT0407530518 locations
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
NCT055441366 locations
First in Human Study of AZD9592 in Solid Tumors
NCT0564712250 locations
Heavy Strength Training in Head and Neck Cancer Survivors
NCT062890491 location
Photobiomodulation Therapy Plus M-health in Head and Neck Cancer Patients: LAXER Study
NCT051066081 location